For years, plastic surgeons thought the proportions of a beautiful buttocks should follow the Fibonacci sequence. Now, people are looking for a more Kardashian shape.
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.
New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive treatments—such as monoclonal antibodies—sooner.
Nitazenes, a class of synthetic drugs 40 times more potent than fentanyl, are steadily becoming more common on both sides of the Atlantic.
By combining LED technology and nanomaterials, researchers have created a therapy that eliminates cancer cells using localized heat without damaging healthy tissue.
The Atlantic CEO’s new book, The Running Ground, examines his complicated relationship with the sport. On this week’s episode of The Big Interview, he talks about the ways tech is helping him become a better runner.
With the demand for human donor organs desperately outstripping supply, scientists are working to see if genetically edited pig organs can bridge the gap.
Every day, millions confide in AI, exposing their most intimate problems and hoping it will fix them. This is the story of two people—and their bots—on the very edge of therapy’s new frontier.
One in six laboratory-confirmed bacteria in 2023 proved resistant to antibiotic treatment, according to the World Health Organization—all related to a variety of common diseases globally.
Researchers confirmed that sperm accumulate mutations over the years, increasing the risk of transmitting diseases to offspring.